PHARMANUTRA SPA (PHN.MI) Stock Fundamental Analysis
BIT:PHN - IT0005274094 - Common Stock
46.4 EUR
-0.9 (-1.9%)
Taking everything into account, PHN scores 8 out of 10 in our fundamental rating. PHN was compared to 13 industry peers in the Personal Care Products industry. PHN scores excellent points on both the profitability and health parts. This is a solid base for a good stock. PHN is growing strongly while it is still valued neutral. This is a good combination! These ratings could make PHN a good candidate for growth and quality investing.
1. Profitability
1.1 Basic Checks
PHN had positive earnings in the past year.
In the past year PHN had a positive cash flow from operations.
PHN had positive earnings in each of the past 5 years.
In the past 5 years PHN always reported a positive cash flow from operatings.
1.2 Ratios
PHN has a better Return On Assets (18.91%) than 100.00% of its industry peers.
The Return On Equity of PHN (36.18%) is better than 100.00% of its industry peers.
The Return On Invested Capital of PHN (23.97%) is better than 100.00% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for PHN is above the industry average of 12.46%.
The 3 year average ROIC (17.21%) for PHN is below the current ROIC(23.97%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 18.91% | ||
| ROE | 36.18% | ||
| ROIC | 23.97% |
ROA(3y)13.53%
ROA(5y)17.42%
ROE(3y)26.61%
ROE(5y)29.54%
ROIC(3y)17.21%
ROIC(5y)18.21%
1.3 Margins
Looking at the Profit Margin, with a value of 13.77%, PHN is in the better half of the industry, outperforming 76.92% of the companies in the same industry.
In the last couple of years the Profit Margin of PHN has declined.
PHN has a better Operating Margin (22.67%) than 100.00% of its industry peers.
In the last couple of years the Operating Margin of PHN has remained more or less at the same level.
PHN has a Gross Margin of 95.55%. This is amongst the best in the industry. PHN outperforms 100.00% of its industry peers.
PHN's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 22.67% | ||
| PM (TTM) | 13.77% | ||
| GM | 95.55% |
OM growth 3Y-4.84%
OM growth 5Y1.01%
PM growth 3Y-10.74%
PM growth 5Y-1.82%
GM growth 3Y-0.75%
GM growth 5Y-0.04%
2. Health
2.1 Basic Checks
PHN has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
The number of shares outstanding for PHN remains at a similar level compared to 1 year ago.
PHN has less shares outstanding than it did 5 years ago.
PHN has a better debt/assets ratio than last year.
2.2 Solvency
An Altman-Z score of 8.23 indicates that PHN is not in any danger for bankruptcy at the moment.
PHN has a Altman-Z score of 8.23. This is amongst the best in the industry. PHN outperforms 100.00% of its industry peers.
PHN has a debt to FCF ratio of 1.16. This is a very positive value and a sign of high solvency as it would only need 1.16 years to pay back of all of its debts.
PHN's Debt to FCF ratio of 1.16 is amongst the best of the industry. PHN outperforms 92.31% of its industry peers.
A Debt/Equity ratio of 0.30 indicates that PHN is not too dependend on debt financing.
With a Debt to Equity ratio value of 0.30, PHN perfoms like the industry average, outperforming 53.85% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.3 | ||
| Debt/FCF | 1.16 | ||
| Altman-Z | 8.23 |
ROIC/WACC3.05
WACC7.85%
2.3 Liquidity
PHN has a Current Ratio of 2.29. This indicates that PHN is financially healthy and has no problem in meeting its short term obligations.
With an excellent Current ratio value of 2.29, PHN belongs to the best of the industry, outperforming 92.31% of the companies in the same industry.
PHN has a Quick Ratio of 2.02. This indicates that PHN is financially healthy and has no problem in meeting its short term obligations.
Looking at the Quick ratio, with a value of 2.02, PHN belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.29 | ||
| Quick Ratio | 2.02 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 29.72% over the past year.
The Earnings Per Share has been growing by 14.63% on average over the past years. This is quite good.
Looking at the last year, PHN shows a quite strong growth in Revenue. The Revenue has grown by 16.16% in the last year.
The Revenue has been growing by 16.59% on average over the past years. This is quite good.
EPS 1Y (TTM)29.72%
EPS 3Y6.71%
EPS 5Y14.63%
EPS Q2Q%-8.63%
Revenue 1Y (TTM)16.16%
Revenue growth 3Y19.25%
Revenue growth 5Y16.59%
Sales Q2Q%11.2%
3.2 Future
The Earnings Per Share is expected to grow by 14.27% on average over the next years. This is quite good.
Based on estimates for the next years, PHN will show a quite strong growth in Revenue. The Revenue will grow by 12.00% on average per year.
EPS Next Y13.36%
EPS Next 2Y15.1%
EPS Next 3Y14.27%
EPS Next 5YN/A
Revenue Next Year14.01%
Revenue Next 2Y13.58%
Revenue Next 3Y12%
Revenue Next 5YN/A
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 19.17 indicates a rather expensive valuation of PHN.
Based on the Price/Earnings ratio, PHN is valued cheaper than 84.62% of the companies in the same industry.
When comparing the Price/Earnings ratio of PHN to the average of the S&P500 Index (27.06), we can say PHN is valued slightly cheaper.
The Price/Forward Earnings ratio is 18.41, which indicates a rather expensive current valuation of PHN.
PHN's Price/Forward Earnings is on the same level as the industry average.
The average S&P500 Price/Forward Earnings ratio is at 22.69. PHN is around the same levels.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 19.17 | ||
| Fwd PE | 18.41 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, PHN is valued a bit cheaper than the industry average as 61.54% of the companies are valued more expensively.
Based on the Price/Free Cash Flow ratio, PHN is valued a bit cheaper than 61.54% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 21.71 | ||
| EV/EBITDA | 10.48 |
4.3 Compensation for Growth
The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
The excellent profitability rating of PHN may justify a higher PE ratio.
PHN's earnings are expected to grow with 14.27% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.43
PEG (5Y)1.31
EPS Next 2Y15.1%
EPS Next 3Y14.27%
5. Dividend
5.1 Amount
PHN has a Yearly Dividend Yield of 2.06%. Purely for dividend investing, there may be better candidates out there.
PHN's Dividend Yield is a higher than the industry average which is at 2.43.
Compared to an average S&P500 Dividend Yield of 2.32, PHN has a dividend comparable with the average S&P500 company.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.06% |
5.2 History
The dividend of PHN is nicely growing with an annual growth rate of 11.21%!
Dividend Growth(5Y)11.21%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
PHN pays out 35.05% of its income as dividend. This is a sustainable payout ratio.
The dividend of PHN is growing, but earnings are growing more, so the dividend growth is sustainable.
DP35.05%
EPS Next 2Y15.1%
EPS Next 3Y14.27%
BIT:PHN (9/5/2025, 7:00:00 PM)
46.4
-0.9 (-1.9%)
Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupHousehold & Personal Products
GICS IndustryPersonal Care Products
Earnings (Last)
Earnings (Next)
Inst Owners15.44%
Inst Owner ChangeN/A
Ins Owners65.02%
Ins Owner ChangeN/A
Market Cap449.15M
Analysts83.33
Price Target80.58 (73.66%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.06% |
Yearly Dividend0.85
Dividend Growth(5Y)11.21%
DP35.05%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-3.66%
PT rev (3m)-4.82%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-2.66%
EPS NY rev (3m)-2.66%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.33%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 19.17 | ||
| Fwd PE | 18.41 | ||
| P/S | 2.65 | ||
| P/FCF | 21.71 | ||
| P/OCF | 18.07 | ||
| P/B | 6.97 | ||
| P/tB | 10.99 | ||
| EV/EBITDA | 10.48 |
EPS(TTM)2.42
EY5.22%
EPS(NY)2.52
Fwd EY5.43%
FCF(TTM)2.14
FCFY4.61%
OCF(TTM)2.57
OCFY5.53%
SpS17.49
BVpS6.66
TBVpS4.22
PEG (NY)1.43
PEG (5Y)1.31
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 18.91% | ||
| ROE | 36.18% | ||
| ROCE | 41.7% | ||
| ROIC | 23.97% | ||
| ROICexc | 35.83% | ||
| ROICexgc | 57.7% | ||
| OM | 22.67% | ||
| PM (TTM) | 13.77% | ||
| GM | 95.55% | ||
| FCFM | 12.22% |
ROA(3y)13.53%
ROA(5y)17.42%
ROE(3y)26.61%
ROE(5y)29.54%
ROIC(3y)17.21%
ROIC(5y)18.21%
ROICexc(3y)25.61%
ROICexc(5y)33.67%
ROICexgc(3y)43.23%
ROICexgc(5y)50.61%
ROCE(3y)29.76%
ROCE(5y)31.61%
ROICexcg growth 3Y-15.98%
ROICexcg growth 5Y-10.26%
ROICexc growth 3Y-20.69%
ROICexc growth 5Y-11.75%
OM growth 3Y-4.84%
OM growth 5Y1.01%
PM growth 3Y-10.74%
PM growth 5Y-1.82%
GM growth 3Y-0.75%
GM growth 5Y-0.04%
F-Score8
Asset Turnover1.37
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.3 | ||
| Debt/FCF | 1.16 | ||
| Debt/EBITDA | 0.46 | ||
| Cap/Depr | 106.2% | ||
| Cap/Sales | 2.46% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 58.76% | ||
| Profit Quality | 88.74% | ||
| Current Ratio | 2.29 | ||
| Quick Ratio | 2.02 | ||
| Altman-Z | 8.23 |
F-Score8
WACC7.85%
ROIC/WACC3.05
Cap/Depr(3y)763.09%
Cap/Depr(5y)544.05%
Cap/Sales(3y)14.97%
Cap/Sales(5y)11.04%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)29.72%
EPS 3Y6.71%
EPS 5Y14.63%
EPS Q2Q%-8.63%
EPS Next Y13.36%
EPS Next 2Y15.1%
EPS Next 3Y14.27%
EPS Next 5YN/A
Revenue 1Y (TTM)16.16%
Revenue growth 3Y19.25%
Revenue growth 5Y16.59%
Sales Q2Q%11.2%
Revenue Next Year14.01%
Revenue Next 2Y13.58%
Revenue Next 3Y12%
Revenue Next 5YN/A
EBIT growth 1Y19.75%
EBIT growth 3Y13.47%
EBIT growth 5Y17.77%
EBIT Next Year24.88%
EBIT Next 3Y16.72%
EBIT Next 5Y9.17%
FCF growth 1Y235.79%
FCF growth 3Y1.75%
FCF growth 5Y17.94%
OCF growth 1Y134.99%
OCF growth 3Y0.14%
OCF growth 5Y11.34%